COPALIS ONE IMMUNOASSAY SYSTEM/TOXOPLASMA GONDII/RUBELLA/CMV TOTAL ANTIBODY ASSAYS

Latex Agglutination Assay, Rubella

SIENNA BIOTECH, INC.

The following data is part of a premarket notification filed by Sienna Biotech, Inc. with the FDA for Copalis One Immunoassay System/toxoplasma Gondii/rubella/cmv Total Antibody Assays.

Pre-market Notification Details

Device IDK961784
510k NumberK961784
Device Name:COPALIS ONE IMMUNOASSAY SYSTEM/TOXOPLASMA GONDII/RUBELLA/CMV TOTAL ANTIBODY ASSAYS
ClassificationLatex Agglutination Assay, Rubella
Applicant SIENNA BIOTECH, INC. 9115 GUILFORD RD. SUITE 180 Columbia,  MD  21046 -1893
ContactJudith J Smith
CorrespondentJudith J Smith
SIENNA BIOTECH, INC. 9115 GUILFORD RD. SUITE 180 Columbia,  MD  21046 -1893
Product CodeLQN  
CFR Regulation Number866.3510 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1996-05-02
Decision Date1996-10-31
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.